Walleye Trading
AGIO icon

Walleye Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Walleye Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,200
Closed -$931K – 4262
2025
Q3 		$931K Buy
+23,200
New +$873K ﹤0.01% 2325
2023
Q4 		– Sell
-10,200
Closed -$252K – 5031
2023
Q3 		$252K Buy
+10,200
New +$270K ﹤0.01% 3457
2022
Q4 		– Sell
-14,500
Closed -$410K – 4917
2022
Q3 		$410K Buy
+14,500
New +$389K ﹤0.01% 3081
2022
Q2 		– Sell
-6,000
Closed -$175K – 5052
2022
Q1 		$175K Sell
6,000
-1,400
-19% -$42.8K ﹤0.01% 3900
2021
Q4 		$243K Sell
7,400
-4,000
-35% -$161K ﹤0.01% 3695
2021
Q3 		$526K Buy
+11,400
New +$551K ﹤0.01% 2862
2021
Q1 		– Sell
-200
Closed -$9K – 4737
2020
Q4 		$9K Buy
+200
New +$7.91K ﹤0.01% 4456
2020
Q3 		– Sell
-37,900
Closed -$2.03M – 4037
2020
Q2 		$2.03M Sell
37,900
-58,700
-61% -$2.72M 0.01% 1081
2020
Q1 		$3.43M Sell
96,600
-17,000
-15% -$786K 0.03% 548
2019
Q4 		$5.42M Buy
113,600
+96,500
+564% +$3.65M 0.04% 536
2019
Q3 		$554K Sell
17,100
-17,500
-51% -$724K ﹤0.01% 2050
2019
Q2 		$1.73M Buy
34,600
+20,800
+151% +$1.11M 0.01% 1161
2019
Q1 		$931K Buy
13,800
+3,100
+29% +$181K 0.01% 1733
2018
Q4 		$493K Sell
10,700
-7,300
-41% -$451K ﹤0.01% 2491
2018
Q3 		$1.39M Buy
18,000
+11,700
+186% +$941K 0.01% 1729
2018
Q2 		$531K Buy
+6,300
New +$549K ﹤0.01% 2785

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Walleye Trading's AGIO Position: Q1 2024 in Review

Walleye Trading sold out of Agios Pharmaceuticals (AGIO) in Q1 2024, closing a stake of 20,321 shares — an estimated $453K sold.

Walleye Trading first reported a position in AGIO in Q2 2017 and held it in 11 quarters. The position peaked at $1.13M in Q4 2018. 186 funds tracked by Wall St. Rank hold AGIO as of Q1 2024.

  • Walleye Trading reported no remaining Agios Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 20,321 Agios Pharmaceuticals shares in Q1 2024, an estimated $453K.
  • Walleye Trading first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 11 quarters.
  • Walleye Trading's Agios Pharmaceuticals position peaked at $1.13M in Q4 2018.
  • 186 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.